RA Capital Management 13F holdings, Q1 2022
Holdings as of March 31, 2022 · filings on SEC EDGAR · latest filing →
RA Capital Management disclosed 96 US equity positions worth $4.6bn in its Q1 2022 13F filing. The largest position was ASND at 19.4% of the reported book, followed by BIIB and AEROVATE THERAPEUTICS INC. Against the Q4 2021 filing, it opened 8 new positions, added to 11 and reduced 2 among the top 50 holdings.
What did RA Capital Management own in Q1 2022? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2021 |
|---|---|---|---|---|---|---|---|
| 1 | ASND ASCENDIS PHARMA A/S | Healthcare | 19.4% | $888.2m | 7,567,900 | 0% | held |
| 2 | BIIB BIOGEN INC | Healthcare | 3.3% | $153.1m | 727,024 | – | new |
| 3 | AEROVATE THERAPEUTICS INC | 3.3% | $151.5m | 8,263,982 | 0% | held | |
| 4 | CTKB CYTEK BIOSCIENCES INC | Healthcare | 3.1% | $144.2m | 13,381,054 | 39% | added |
| 5 | ITEOS THERAPEUTICS INC | 3.1% | $142.1m | 4,417,259 | 0% | held | |
| 6 | TVTX TRAVERE THERAPEUTICS INC | Healthcare | 2.8% | $126.9m | 4,922,941 | -12% | reduced |
| 7 | JANX JANUX THERAPEUTICS INC | Healthcare | 2.7% | $124.3m | 8,670,644 | 0% | held |
| 8 | PCVX VAXCYTE INC | Healthcare | 2.4% | $110.6m | 4,581,203 | 8% | added |
| 9 | CLYM ELIEM THERAPEUTICS INC | 2.4% | $110.3m | 13,150,849 | 0% | held | |
| 10 | IMMUNOGEN INC | 2.3% | $103.5m | 21,741,458 | 7% | added | |
| 11 | DICE THERAPEUTICS INC | 2.2% | $99.6m | 5,208,911 | 0% | held | |
| 12 | GHRS GH RESEARCH PLC | 1.9% | $88.3m | 4,827,330 | 70% | added | |
| 13 | FORMA THERAPEUTICS HLDGS INC | 1.8% | $83.8m | 9,011,651 | 0% | held | |
| 14 | TYRA TYRA BIOSCIENCES INC | Healthcare | 1.7% | $77.4m | 7,236,454 | 0% | held |
| 15 | POINT BIOPHARMA GLOBAL INC | 1.6% | $71.8m | 9,003,018 | 0% | held | |
| 16 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 1.5% | $70.7m | 2,075,000 | 15% | added |
| 17 | BELLUS HEALTH INC NEW | 1.5% | $70.4m | 10,230,274 | 0% | held | |
| 18 | ENTA ENANTA PHARMACEUTICALS INC | Healthcare | 1.5% | $68.6m | 964,212 | – | new |
| 19 | VOR VOR BIOPHARMA INC | 1.5% | $67.2m | 11,120,973 | 0% | held | |
| 20 | NKTX NKARTA INC | Healthcare | 1.4% | $63.8m | 5,605,129 | 0% | held |
| 21 | MIRATI THERAPEUTICS INC | 1.3% | $60.4m | 734,343 | 93% | added | |
| 22 | DAWNGBX DAY ONE BIOPHARMACEUTICALS I | 1.3% | $60.1m | 6,060,090 | 22% | added | |
| 23 | RYTM RHYTHM PHARMACEUTICALS INC | Healthcare | 1.2% | $56.1m | 4,871,067 | 0% | held |
| 24 | ANTX AN2 THERAPEUTICS INC | 1.2% | $55.3m | 3,666,663 | – | new | |
| 25 | RLMD RELMADA THERAPEUTICS INC | Healthcare | 1.2% | $54.0m | 2,000,000 | 0% | held |
| 26 | MGNX MACROGENICS INC | Healthcare | 1.2% | $53.8m | 6,103,594 | 0% | held |
| 27 | NTRA NATERA INC | Healthcare | 1.2% | $53.3m | 1,310,289 | – | new |
| 28 | TIL INSTIL BIO INC | 1.1% | $52.4m | 4,870,793 | 0% | held | |
| 29 | NVAX NOVAVAX INC | Healthcare | 1.1% | $51.0m | 692,794 | -67% | reduced |
| 30 | KINNATE BIOPHARMA INC | 1.0% | $48.0m | 4,264,144 | 19% | added | |
| 31 | VERA VERA THERAPEUTICS INC | Healthcare | 1.0% | $46.2m | 1,966,084 | – | new |
| 32 | PARDES BIOSCIENCES INC | 1.0% | $44.6m | 6,175,038 | 97% | added | |
| 33 | ICOSAVAX INC | 0.9% | $42.0m | 5,963,565 | 3% | added | |
| 34 | TNYA TENAYA THERAPEUTICS INC | 0.9% | $41.8m | 3,551,508 | 0% | held | |
| 35 | GERN GERON CORP | Healthcare | 0.9% | $41.0m | 30,126,299 | 0% | held |
| 36 | EYPT EYEPOINT PHARMACEUTICALS INC | Healthcare | 0.9% | $41.0m | 3,370,506 | 0% | held |
| 37 | AVIDITY BIOSCIENCES INC | 0.9% | $40.0m | 2,167,391 | 412% | added | |
| 38 | ABOS ACUMEN PHARMACEUTICALS INC | 0.8% | $38.2m | 9,770,773 | 0% | held | |
| 39 | RXST RXSIGHT INC | Healthcare | 0.8% | $37.8m | 3,052,796 | 0% | held |
| 40 | PMVP PMV PHARMACEUTICALS INC | 0.8% | $35.6m | 1,710,265 | 0% | held | |
| 41 | DSGN DESIGN THERAPEUTICS INC | Healthcare | 0.8% | $35.3m | 2,186,636 | 0% | held |
| 42 | RCKT ROCKET PHARMACEUTICALS INC | Healthcare | 0.7% | $33.4m | 2,107,149 | 0% | held |
| 43 | CNTA CENTESSA PHARMACEUTICALS PLC | 0.7% | $32.1m | 3,577,094 | 0% | held | |
| 44 | GH GUARDANT HEALTH INC | Healthcare | 0.7% | $31.6m | 476,380 | – | new |
| 45 | ACRS ACLARIS THERAPEUTICS INC | Healthcare | 0.7% | $31.3m | 1,817,808 | – | new |
| 46 | CHEMOCENTRYX INC | 0.6% | $29.0m | 1,155,964 | – | new | |
| 47 | 4XC1 KALVISTA PHARMACEUTICALS INC | 0.6% | $28.5m | 1,930,322 | 0% | held | |
| 48 | LIANY LIANBIO | 0.6% | $28.4m | 7,655,015 | 0% | held | |
| 49 | DYN DYNE THERAPEUTICS INC | Healthcare | 0.6% | $27.0m | 2,805,045 | 0% | held |
| 50 | VRNA VERONA PHARMA PLC | 0.6% | $25.4m | 5,100,000 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.